TrialJapanese journal of ophthalmology2012

Topical loteprednol etabonate 0.5 % for treatment of vernal keratoconjunctivitis: efficacy and safety.

Veysi Oner et al.PubMed ↗Publisher ↗

No numbers read from the abstract.